ニュース

Telesat (TSAT.TO) on Tuesday reported net loss which narrowed in the fourth quarter, despite a lower

UBS downgrade puts Infineon’s AI and China auto exposure in focus UBS cut its rating on Infineon Technologies (XTRA:IFX) to Neutral, highlighting what it sees as limited upside in the company’s AI-related business and forecasting 7% annual declines in China auto revenue in 2026 and 2027. See our latest analysis for Infineon Technologies. Infineon’s shares have been choppy recently, with a 1 month share price return of an 8.45% decline, even as the 90 day share price return of 9.77% and 1 year...

Seadrill delivers offshore drilling services worldwide, serving oil majors with a fleet of advanced rigs and a global client base.

Energy stocks fell Tuesday with the NYSE Energy Sector Index decreasing 0.8% and the State Street En

Although affordability challenges and land/labor costs pose risks, better operating leverage and marketing strategies are likely to drive homebuilders like TOL and GRBK.

Small caps are enjoying a renaissance in 2026. This ETF targets the space better than the others.

In late 2025, SELLAS Life Sciences Group reported encouraging Phase 2 data for SLS009 in combination with azacitidine and venetoclax in relapsed or refractory acute myeloid leukemia and confirmed that its Phase 3 REGAL trial of Galinpepimut-S would continue unchanged after an Independent Data Monitoring Committee review. Taken together, these developments highlight both near-term clinical momentum around SLS009 and growing validation of Galinpepimut-S as a potential maintenance therapy in...

Executives at DeFi Development (NASDAQ:DFDV) used a monthly business recap and question-and-answer session to review February activity, discuss a reduction in near-term guidance tied to market conditions, and outline how a recent investment in a new stablecoin protocol could support future fundraisi

SELLAS Life Sciences Group (SLS) is back in focus after encouraging clinical updates on its leukemia programs, including Phase 2 data for SLS009 and ongoing progress in the Phase 3 REGAL trial for Galinpepimut S. See our latest analysis for SELLAS Life Sciences Group. The recent clinical updates appear to be reflected in momentum, with a 44.8% 1 month share price return, a 217.8% 3 month share price return and a very large 1 year total shareholder return, although the 5 year total shareholder...

It was the rise of the rank and file for the last few months but with their slips, is it time for more cash?

US equity indexes fell on Friday amid weaker-than-expected February jobs data and higher inflation f

Report suggests thicker HBM designs could delay hybrid bonding adoption

The European stock markets closed lower in Friday trading as war in the Middle East has caused oil p

Richtech Robotics (NasdaqCM:RR) is facing multiple securities class action lawsuits over allegations that it misrepresented the nature of its relationship with Microsoft. Microsoft has reportedly said the engagement is limited to a standard customer program, not a broader commercial partnership. Law firms are seeking shareholders to act as lead plaintiffs, with regulatory attention increasing as key filing deadlines approach. For investors watching Richtech Robotics at a share price of...

The Dow Jones index fell and other indexes were mixed after President Trump spoke on Iran. A Warren Buffett stock dived but Palantir popped. Oil and defense stocks rose.

Rackspace Technology (NASDAQ:RXT) just reported its fourth-quarter results, showcasing signs of business improvement amid a challenging market. Revenue stabilized with only a slight decline, losses narrowed significantly, and key metrics beat analyst expectations. This comes on the heels of its recent partnership with Palantir Technologies (NASDAQ:PLTR), aimed at accelerating AI deployments. Yet, despite these positives, ... Rackspace Tumbles as Business Improves, but Is It a Buy Yet?

Asian equities traded in the US as American depositary receipts were sharply lower Friday morning, d

Not one, but two factors are leading a sell-off.

Palo Alto Networks shares slumped Wednesday after the cybersecurity software firm lowered its profit forecast for the year.

Company lowers full-year and Q3 adjusted EPS guidance while projecting revenue above Wall Street estimates.

Berkshire Hathaway late Tuesday disclosed a new position in the New York Times valued at about $350 million. Warren Buffett's Berkshire reduced positions in Apple, BofA and Amazon. Late Tuesday, New York Times shares rose 3% to a new high as Berkshire's stake became public.

Quantum Stocks Tank as Investors Pivot to Value; QUBT Defies Trend

Turbo Energy (TURB) announced the completion of a restructuring of its bank financing aimed at strengthening its financial position and aligning liquidity with the Company’s medium- and long-term business plan. As part of this process, Turbo Energy reached agreements with Bankinter, CaixaBank and BBVA, three of Spain’s leading financial institutions, enabling the conversion of existing bank facilities into long-term financing structures totaling approximately EUR 4.87M. This reorganization stren

One crypto observer suspects a fund holding Bitcoin call options got wiped out, triggering a broader crash.

SanDisk (SNDK) stock just got one of the most aggressive votes of confidence on Wall Street. Bernstein SocGen Group analyst Mark C. Newman just dropped a jaw-dropping new price target of $1,000 on the memory chip players' stock while keeping an outperform rating. The new target represents a 72.4% ...

Upexi (NASDAQ: UPXI) has terminated its asset management agreement with crypto research and trading firm GSR Strategies. According to a Form 8-K filing with the U.S. Securities and Exchange Commission, the termination became effective on Dec. 26, 2025, following months of disputes ...

Advanced Biomed (ADVB) entered into an agreement with an unrelated third party, Wei Ha Hui, pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed Limited, a Hong Kong company and a wholly owned subsidiary of the Company, for an aggregate purchase price of $23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement. All intellectual property owned by the Hong Kong subsidiary, in

For investors looking to access the growth potential of mid-cap stocks, this ETF is one to hold for the long term.